Contract facts
FederalNo full NAICS 561320 intel page yet. Browse NAICS intelligence
Histopathology Technologist/Technician at the Dallas Veterans Medical CENTER. Option Year Two 03/01/2026 - 02/28/2025 is a federal award for 257-Network Contract Office 17 (36C257) held by Ghost Rx Inc. Estimated value $244K ($244K obligated). Current period of performance ends Feb 28, 2027. Place of performance: DALLAS TX.
Histopathology technologist/technician at the dallas veterans medical center. option year two 03/01/2026 - 02/28/2025. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Feb 28, 2027 (112 days remaining). Agencies typically plan 12–18 months ahead — at 3.7 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 36C25726N0096? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordGhost Rx Inc — $71.1M obligated across 221 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25726N0096?
36C25726N0096 (Histopathology technologist technician at the) is a 257-Network Contract Office 17 (36C257) award with a potential value of $244K, currently held by Ghost Rx Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C257-26-N-0096?
36C257-26-N-0096 is the dashed form of contract 36C25726N0096 (Histopathology technologist technician at the), held by Ghost Rx Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25726N0096?
257-Network Contract Office 17 (36C257) awarded 36C25726N0096 to Ghost Rx Inc (potential $244K).
Who is the incumbent on 36C25726N0096?
Ghost Rx Inc is the incumbent with $71.1M across 221 related awards in SCOUT’s public footprint. The current period of performance ends Feb 28, 2027.
When does Ghost Rx Inc’s 36C25726N0096 come up for recompete?
SCOUT tracks a period-of-performance end of Feb 28, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C25726N0096? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by contract number; task orders appear as independent rows.